4 results on '"Archin, Iman"'
Search Results
2. Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances.
- Author
-
Gholami Chahkand, Mohammad Sadra, Tavakoli, Yasaman, Aghakhani, Ava, Askarzadeh, Monireh, Azimi, Hosein, Ghalamkarpour, Nogol, Alizadeh, Alaleh, Archin, Iman, Kermani, Sajad, Ansari, Akram, Poudineh, Mohadeseh, Mali, Zahra, Foroughi, Elaheh, Erabi, Gisou, Mazhari, Seyed Amirhossein, Fallahi, Mohammad Sadegh, Deravi, Niloofar, and Dadkhah, Parisa Alsadat
- Subjects
TYPE 1 diabetes ,TYPE 2 diabetes ,KIDNEY failure ,TOLL-like receptors ,CHRONIC kidney failure - Abstract
Diabetic nephropathy (DN) is one of the most common kidney diseases, but its exact pathophysiology remains unknown. Toll-like receptors (TLRs) are innate immune receptors that recognize pathogen- and danger-associated molecular patterns, which can result in an inflammatory response. TLR4, TLR2, TLR5, TLR7, TLR8, TLR9, and TLR11 are essential in the pathogenesis of DN, according to recent evidence collected from both in vivo and in vitro studies. Studies have shown that TLR2 and TLR4 expression is higher in patients with renal failure and nephrotic diabetes. They also play critical roles in podocyte injury and inflammation caused by high glucose. TLR2 and TLR4 may be helpful therapeutic targets to prevent or delay DN in patients with type 2 diabetes mellitus. Additionally, TLR7 may contribute to kidney damage in type 1 diabetes mellitus, whereas downregulation of TLR9 expression inhibits inflammation and apoptosis pathways associated with DN. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Neuroprotective effects of flavonoids: endoplasmic reticulum as the target.
- Author
-
Amiri, Bita, Tabrizi, Maryam Yazdani, Naziri, Mahdyieh, Moradi, Farzaneh, Arzaghi, Mohammadreza, Archin, Iman, Behaein, Fatemeh, Pour, Anahid Bagheri, Ghannadikhosh, Parna, Imanparvar, Saba, Kohneshahri, Ata Akhtari, Abbasi, Ali Sanaye, Zerangian, Nasibeh, Alijanzadeh, Dorsa, Ghayyem, Hani, Azizinezhad, Arash, Youshanlui, Mahya Ahmadpour, and Poudineh, Mohadeseh
- Subjects
FLAVONOLS ,ENDOPLASMIC reticulum ,FLAVONOIDS ,PLANT polyphenols ,NATURAL wines ,FLAVONES - Abstract
The incidence of neurological disorders, particularly age-related neurodegenerative pathologies, exhibits an alarming upward trend, while current pharmacological interventions seldom achieve curative outcomes. Despite their diverse clinical presentations, neurological diseases often share a common pathological thread: the aberrant accumulation of misfolded proteins within the endoplasmic reticulum (ER). This phenomenon, known as ER stress, arises when the cell's intrinsic quality control mechanisms fail to cope with the protein-folding burden. Consequently, misfolded proteins accumulate in the ER lumen, triggering a cascade of cellular stress responses. Recognizing this challenge, researchers have intensified their efforts over the past two decades to explore natural compounds that could potentially slow or even reverse these devastating pathologies. Flavonoids constitute a vast and heterogeneous class of plant polyphenols, with over 10,000 identified from diverse natural sources such as wines, vegetables, medicinal plants, and organic products. Flavonoids are generally divided into six different subclasses: anthocyanidins, flavanones, flavones, flavonols, isoflavones, and flavonols. The diverse family of flavonoids, featuring a common phenolic ring backbone adorned with varying hydroxyl groups and additional modifications, exerts its antioxidant activity by inhibiting the formation of ROS, as evidenced by research. Also, studies suggest that polyphenols such as flavonoids can regulate ER stress through apoptosis and autophagy. By understanding these mechanisms, we can unlock the potential of flavonoids as novel therapeutic agents for neurodegenerative disorders. Therefore, this review critically examines the literature exploring the modulatory effects of flavonoids on various steps of the ER stress in neurological disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Lipid variability and risk of microvascular complications in patients with diabetes: a systematic review
- Author
-
Tizro, Neda, Archin, Iman, Deravi, Niloofar, Rasouli, Asma, Vaezi, Ali, Ghannadikhosh, Parna, Karimi, Mohammad Amin, Imanparvar, Saba, Dadgar, Kiarash, Salehi, Sakineh, Gharei, Fatemeh, Alishiri, Goharsharieh, and Ansari, Akram
- Subjects
Medicine and Health Sciences - Abstract
Dyslipidemia is a common presentation in individuals with type 2 diabetes mellitus (T2DM), even among those with good glycemic control. Indeed, individuals with T2DM have been found to have abnormally high levels of triglycerides, decreased high-density lipoproteins (HDL), and modest or normal levels of low-density lipoproteins (LDL).In a cross-sectional study of T2DM patients, the researchers found the prevalence of hypertriglyceridemia, abnormal HDL levels (130 mg/dL) to be 61.9%, 54.3%, and 8.9%, respectively,2 similar to the findings of other studies. These abnormal lipid levels have been implicated in the development of several diabetes-related complications including diabetic macrovascular and microvascular disease. Meanwhile, higher variabilities in lipid variables have also been found to be detrimental to health among populations with or without diabetes. For example, in a study of approximately 1000 participants with clinical presentation of coronary disease involved in the Treating to New Target trial, greater variability in HDL, triglyceride, and LDL was found to be associated with cardiovascular events.Also, a recent study of over 10 000 T2DM patients showed that higher variability in HDL, LDL, and total cholesterol appeared to increase the risk of all-cause mortality whereas greater variability in HDL was associated with noncardiovascular deaths.However, few of these studies were on the relationship between lipid variability and diabetic microvascular complications.Diabetic microvascular complications, which comprise nephropathy, neuropathy, and retinopathy, together contribute hugely to the burden of diabetic-related morbidity and mortality.Reports show that during a lifetime, about 20%-40% of patients with T2DM would develop diabetic kidney disease,20 up to 50% would eventually develop diabetic neuropathy,21 and 10% are likely to develop diabetic retinopathy.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.